Earnings Call · Q3 FY2023·2023-10-29

Q3 23EPS -12.90%·Rev n/aQ2 23EPS +7.60%·Rev n/aQ1 23EPS -15.34%·Rev n/aQ4 22EPS -18.87%·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Jane Hanlon — Investor Relations or Corporate Communications (inferred from context)

Matthew Klein — Chief Executive Officer

Eric Pauwels — Chief Business Officer

Kylie O'Keefe — Chief Commercial Officer

Pierre Gravier — Chief Financial Officer

−22.7%1d on move date−22.3% vs SPY3d−21.7%5d−24.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access